nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—ALB—liver cancer	0.65	1	CbGaD
Auranofin—Interstitial pneumonia—Sorafenib—liver cancer	0.00597	0.0637	CcSEcCtD
Auranofin—Nephrotic syndrome—Sorafenib—liver cancer	0.00597	0.0637	CcSEcCtD
Auranofin—Interstitial lung disease—Sorafenib—liver cancer	0.00408	0.0435	CcSEcCtD
Auranofin—PRDX5—embryo—liver cancer	0.00356	0.33	CbGeAlD
Auranofin—Proteinuria—Sorafenib—liver cancer	0.00328	0.035	CcSEcCtD
Auranofin—Protein urine present—Sorafenib—liver cancer	0.00324	0.0346	CcSEcCtD
Auranofin—Glossitis—Sorafenib—liver cancer	0.00313	0.0334	CcSEcCtD
Auranofin—Dermatitis exfoliative—Sorafenib—liver cancer	0.00222	0.0237	CcSEcCtD
Auranofin—IKBKB—embryo—liver cancer	0.00211	0.195	CbGeAlD
Auranofin—ALB—gall bladder—liver cancer	0.00194	0.18	CbGeAlD
Auranofin—Dysphagia—Sorafenib—liver cancer	0.00181	0.0193	CcSEcCtD
Auranofin—Neutropenia—Sorafenib—liver cancer	0.00169	0.0181	CcSEcCtD
Auranofin—PRDX5—liver—liver cancer	0.00164	0.152	CbGeAlD
Auranofin—Weight decreased—Sorafenib—liver cancer	0.00164	0.0175	CcSEcCtD
Auranofin—Neuropathy peripheral—Sorafenib—liver cancer	0.00158	0.0169	CcSEcCtD
Auranofin—Jaundice—Sorafenib—liver cancer	0.00157	0.0168	CcSEcCtD
Auranofin—Stomatitis—Sorafenib—liver cancer	0.00157	0.0168	CcSEcCtD
Auranofin—Gingivitis—Epirubicin—liver cancer	0.00136	0.0145	CcSEcCtD
Auranofin—Alopecia—Sorafenib—liver cancer	0.00128	0.0137	CcSEcCtD
Auranofin—Gingivitis—Doxorubicin—liver cancer	0.00126	0.0134	CcSEcCtD
Auranofin—Dysgeusia—Sorafenib—liver cancer	0.00124	0.0132	CcSEcCtD
Auranofin—Anaemia—Sorafenib—liver cancer	0.00117	0.0124	CcSEcCtD
Auranofin—Glossitis—Epirubicin—liver cancer	0.00116	0.0123	CcSEcCtD
Auranofin—Angioedema—Sorafenib—liver cancer	0.00115	0.0123	CcSEcCtD
Auranofin—Leukopenia—Sorafenib—liver cancer	0.00113	0.012	CcSEcCtD
Auranofin—Glossitis—Doxorubicin—liver cancer	0.00107	0.0114	CcSEcCtD
Auranofin—Melaena—Epirubicin—liver cancer	0.00104	0.0111	CcSEcCtD
Auranofin—Thrombocytopenia—Sorafenib—liver cancer	0.00101	0.0108	CcSEcCtD
Auranofin—Aplastic anaemia—Epirubicin—liver cancer	0.001	0.0107	CcSEcCtD
Auranofin—Anorexia—Sorafenib—liver cancer	0.000982	0.0105	CcSEcCtD
Auranofin—IKBKB—liver—liver cancer	0.000974	0.0903	CbGeAlD
Auranofin—Melaena—Doxorubicin—liver cancer	0.000964	0.0103	CcSEcCtD
Auranofin—Aplastic anaemia—Doxorubicin—liver cancer	0.000927	0.00989	CcSEcCtD
Auranofin—Dyspepsia—Sorafenib—liver cancer	0.000906	0.00967	CcSEcCtD
Auranofin—Decreased appetite—Sorafenib—liver cancer	0.000895	0.00955	CcSEcCtD
Auranofin—Constipation—Sorafenib—liver cancer	0.000881	0.00939	CcSEcCtD
Auranofin—Gastrointestinal pain—Sorafenib—liver cancer	0.000842	0.00898	CcSEcCtD
Auranofin—Dermatitis exfoliative—Epirubicin—liver cancer	0.000821	0.00875	CcSEcCtD
Auranofin—Urticaria—Sorafenib—liver cancer	0.000818	0.00873	CcSEcCtD
Auranofin—Abdominal pain—Sorafenib—liver cancer	0.000814	0.00868	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000774	0.00826	CcSEcCtD
Auranofin—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000759	0.0081	CcSEcCtD
Auranofin—Pruritus—Sorafenib—liver cancer	0.000729	0.00777	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000716	0.00764	CcSEcCtD
Auranofin—Diarrhoea—Sorafenib—liver cancer	0.000705	0.00752	CcSEcCtD
Auranofin—Dysphagia—Epirubicin—liver cancer	0.000669	0.00714	CcSEcCtD
Auranofin—Eosinophilia—Epirubicin—liver cancer	0.000663	0.00707	CcSEcCtD
Auranofin—Vomiting—Sorafenib—liver cancer	0.000655	0.00699	CcSEcCtD
Auranofin—Rash—Sorafenib—liver cancer	0.000649	0.00693	CcSEcCtD
Auranofin—Dermatitis—Sorafenib—liver cancer	0.000649	0.00692	CcSEcCtD
Auranofin—Pancytopenia—Epirubicin—liver cancer	0.000636	0.00678	CcSEcCtD
Auranofin—Neutropenia—Epirubicin—liver cancer	0.000626	0.00668	CcSEcCtD
Auranofin—Dysphagia—Doxorubicin—liver cancer	0.000619	0.00661	CcSEcCtD
Auranofin—Eosinophilia—Doxorubicin—liver cancer	0.000613	0.00654	CcSEcCtD
Auranofin—Nausea—Sorafenib—liver cancer	0.000612	0.00653	CcSEcCtD
Auranofin—Weight decreased—Epirubicin—liver cancer	0.000605	0.00646	CcSEcCtD
Auranofin—Pancytopenia—Doxorubicin—liver cancer	0.000588	0.00627	CcSEcCtD
Auranofin—Neuropathy peripheral—Epirubicin—liver cancer	0.000585	0.00624	CcSEcCtD
Auranofin—Jaundice—Epirubicin—liver cancer	0.000582	0.00621	CcSEcCtD
Auranofin—Stomatitis—Epirubicin—liver cancer	0.000582	0.00621	CcSEcCtD
Auranofin—Conjunctivitis—Epirubicin—liver cancer	0.00058	0.00619	CcSEcCtD
Auranofin—Neutropenia—Doxorubicin—liver cancer	0.000579	0.00618	CcSEcCtD
Auranofin—Haematuria—Epirubicin—liver cancer	0.000569	0.00607	CcSEcCtD
Auranofin—ALB—liver—liver cancer	0.000569	0.0527	CbGeAlD
Auranofin—Weight decreased—Doxorubicin—liver cancer	0.00056	0.00598	CcSEcCtD
Auranofin—Agranulocytosis—Epirubicin—liver cancer	0.000557	0.00594	CcSEcCtD
Auranofin—Neuropathy peripheral—Doxorubicin—liver cancer	0.000541	0.00577	CcSEcCtD
Auranofin—Stomatitis—Doxorubicin—liver cancer	0.000538	0.00574	CcSEcCtD
Auranofin—Jaundice—Doxorubicin—liver cancer	0.000538	0.00574	CcSEcCtD
Auranofin—Conjunctivitis—Doxorubicin—liver cancer	0.000537	0.00573	CcSEcCtD
Auranofin—Haematuria—Doxorubicin—liver cancer	0.000526	0.00562	CcSEcCtD
Auranofin—Visual impairment—Epirubicin—liver cancer	0.000516	0.00551	CcSEcCtD
Auranofin—Agranulocytosis—Doxorubicin—liver cancer	0.000515	0.0055	CcSEcCtD
Auranofin—Eye disorder—Epirubicin—liver cancer	0.000501	0.00534	CcSEcCtD
Auranofin—Visual impairment—Doxorubicin—liver cancer	0.000478	0.0051	CcSEcCtD
Auranofin—Alopecia—Epirubicin—liver cancer	0.000473	0.00505	CcSEcCtD
Auranofin—Eye disorder—Doxorubicin—liver cancer	0.000463	0.00494	CcSEcCtD
Auranofin—Flatulence—Epirubicin—liver cancer	0.000459	0.0049	CcSEcCtD
Auranofin—Dysgeusia—Epirubicin—liver cancer	0.000457	0.00487	CcSEcCtD
Auranofin—Alopecia—Doxorubicin—liver cancer	0.000438	0.00467	CcSEcCtD
Auranofin—Anaemia—Epirubicin—liver cancer	0.000431	0.0046	CcSEcCtD
Auranofin—Flatulence—Doxorubicin—liver cancer	0.000425	0.00454	CcSEcCtD
Auranofin—Dysgeusia—Doxorubicin—liver cancer	0.000423	0.00451	CcSEcCtD
Auranofin—Leukopenia—Epirubicin—liver cancer	0.000417	0.00445	CcSEcCtD
Auranofin—Anaemia—Doxorubicin—liver cancer	0.000399	0.00425	CcSEcCtD
Auranofin—Leukopenia—Doxorubicin—liver cancer	0.000386	0.00412	CcSEcCtD
Auranofin—Thrombocytopenia—Epirubicin—liver cancer	0.000373	0.00398	CcSEcCtD
Auranofin—Anorexia—Epirubicin—liver cancer	0.000363	0.00387	CcSEcCtD
Auranofin—Thrombocytopenia—Doxorubicin—liver cancer	0.000345	0.00368	CcSEcCtD
Auranofin—Anorexia—Doxorubicin—liver cancer	0.000336	0.00358	CcSEcCtD
Auranofin—Dyspepsia—Epirubicin—liver cancer	0.000335	0.00357	CcSEcCtD
Auranofin—Decreased appetite—Epirubicin—liver cancer	0.000331	0.00353	CcSEcCtD
Auranofin—Constipation—Epirubicin—liver cancer	0.000325	0.00347	CcSEcCtD
Auranofin—Gastrointestinal pain—Epirubicin—liver cancer	0.000311	0.00332	CcSEcCtD
Auranofin—Dyspepsia—Doxorubicin—liver cancer	0.00031	0.00331	CcSEcCtD
Auranofin—Decreased appetite—Doxorubicin—liver cancer	0.000306	0.00327	CcSEcCtD
Auranofin—Urticaria—Epirubicin—liver cancer	0.000302	0.00323	CcSEcCtD
Auranofin—Constipation—Doxorubicin—liver cancer	0.000301	0.00321	CcSEcCtD
Auranofin—Abdominal pain—Epirubicin—liver cancer	0.000301	0.00321	CcSEcCtD
Auranofin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000288	0.00307	CcSEcCtD
Auranofin—Urticaria—Doxorubicin—liver cancer	0.00028	0.00298	CcSEcCtD
Auranofin—Abdominal pain—Doxorubicin—liver cancer	0.000278	0.00297	CcSEcCtD
Auranofin—Pruritus—Epirubicin—liver cancer	0.000269	0.00287	CcSEcCtD
Auranofin—Diarrhoea—Epirubicin—liver cancer	0.00026	0.00278	CcSEcCtD
Auranofin—Pruritus—Doxorubicin—liver cancer	0.000249	0.00266	CcSEcCtD
Auranofin—Vomiting—Epirubicin—liver cancer	0.000242	0.00258	CcSEcCtD
Auranofin—Diarrhoea—Doxorubicin—liver cancer	0.000241	0.00257	CcSEcCtD
Auranofin—Rash—Epirubicin—liver cancer	0.00024	0.00256	CcSEcCtD
Auranofin—Dermatitis—Epirubicin—liver cancer	0.00024	0.00256	CcSEcCtD
Auranofin—Nausea—Epirubicin—liver cancer	0.000226	0.00241	CcSEcCtD
Auranofin—Vomiting—Doxorubicin—liver cancer	0.000224	0.00239	CcSEcCtD
Auranofin—Rash—Doxorubicin—liver cancer	0.000222	0.00237	CcSEcCtD
Auranofin—Dermatitis—Doxorubicin—liver cancer	0.000222	0.00237	CcSEcCtD
Auranofin—Nausea—Doxorubicin—liver cancer	0.000209	0.00223	CcSEcCtD
Auranofin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	0.000112	0.000457	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL6—liver cancer	0.000112	0.000457	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CD—liver cancer	0.000112	0.000454	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CD—liver cancer	0.00011	0.000446	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—VEGFA—liver cancer	0.000109	0.000444	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TNF—liver cancer	0.000109	0.000444	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—HGF—liver cancer	0.000109	0.000444	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—AKT1—liver cancer	0.000109	0.000442	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—IL6—liver cancer	0.000108	0.000441	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL6—liver cancer	0.000108	0.00044	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—CSF2—liver cancer	0.000108	0.000439	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PRKCE—liver cancer	0.000107	0.000435	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MYC—liver cancer	0.000105	0.000427	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TGFB1—liver cancer	0.000105	0.000426	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—liver cancer	0.000104	0.000423	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—PIK3CA—liver cancer	0.000104	0.000422	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—liver cancer	0.000102	0.000415	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ABL1—liver cancer	0.000102	0.000414	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—TGFB1—liver cancer	0.0001	0.000408	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—RAF1—liver cancer	9.96e-05	0.000405	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SHC3—liver cancer	9.86e-05	0.000401	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—RAF1—liver cancer	9.79e-05	0.000398	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—liver cancer	9.78e-05	0.000398	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—liver cancer	9.75e-05	0.000397	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CB—liver cancer	9.72e-05	0.000395	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—KRAS—liver cancer	9.71e-05	0.000395	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—liver cancer	9.63e-05	0.000392	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CB—liver cancer	9.56e-05	0.000389	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MTOR—liver cancer	9.56e-05	0.000389	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—liver cancer	9.55e-05	0.000388	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SERPINA1—liver cancer	9.54e-05	0.000388	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	9.48e-05	0.000386	CbGpPWpGaD
Auranofin—ALB—Metabolism—UGDH—liver cancer	9.45e-05	0.000384	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—HRAS—liver cancer	9.33e-05	0.00038	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—liver cancer	9.31e-05	0.000379	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—PIK3CA—liver cancer	9.27e-05	0.000377	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—liver cancer	9.19e-05	0.000374	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD8A—liver cancer	9.1e-05	0.00037	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—IL6—liver cancer	9.08e-05	0.000369	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CDKN1B—liver cancer	8.97e-05	0.000365	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—liver cancer	8.96e-05	0.000364	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL2—liver cancer	8.93e-05	0.000363	CbGpPWpGaD
Auranofin—ALB—Metabolism—EPT1—liver cancer	8.89e-05	0.000362	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL6—liver cancer	8.81e-05	0.000358	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CASP3—liver cancer	8.79e-05	0.000357	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—MAPK14—liver cancer	8.74e-05	0.000355	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—liver cancer	8.67e-05	0.000353	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—liver cancer	8.63e-05	0.000351	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—KRAS—liver cancer	8.61e-05	0.00035	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—HRAS—liver cancer	8.58e-05	0.000349	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ADAM17—liver cancer	8.56e-05	0.000348	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PIK3CA—liver cancer	8.55e-05	0.000348	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—liver cancer	8.48e-05	0.000345	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—F2—liver cancer	8.47e-05	0.000344	CbGpPWpGaD
Auranofin—ALB—Metabolism—TAT—liver cancer	8.43e-05	0.000343	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—liver cancer	8.29e-05	0.000337	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	8.29e-05	0.000337	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CDKN1A—liver cancer	8.28e-05	0.000337	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—AKT1—liver cancer	8.24e-05	0.000335	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—BCL2L1—liver cancer	8.1e-05	0.00033	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CG—liver cancer	8.1e-05	0.000329	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK8—liver cancer	8.08e-05	0.000329	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PSMA4—liver cancer	8.05e-05	0.000327	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PSMD10—liver cancer	8.05e-05	0.000327	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PIK3CA—liver cancer	7.91e-05	0.000322	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—liver cancer	7.91e-05	0.000322	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK14—liver cancer	7.67e-05	0.000312	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FST—liver cancer	7.66e-05	0.000311	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—AKT1—liver cancer	7.57e-05	0.000308	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—liver cancer	7.57e-05	0.000308	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—STAT3—liver cancer	7.51e-05	0.000306	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—STAT3—liver cancer	7.39e-05	0.0003	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—HRAS—liver cancer	7.32e-05	0.000298	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—liver cancer	7.32e-05	0.000298	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TRIO—liver cancer	7.3e-05	0.000297	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—AKT1—liver cancer	7.28e-05	0.000296	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	7.12e-05	0.00029	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IFNA1—liver cancer	7.11e-05	0.000289	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNA1—liver cancer	7.05e-05	0.000287	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	7.04e-05	0.000286	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR4—liver cancer	7e-05	0.000285	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL6—liver cancer	7e-05	0.000285	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—liver cancer	6.99e-05	0.000284	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—AKT1—liver cancer	6.47e-05	0.000263	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—KRAS—liver cancer	6.45e-05	0.000262	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—RAF1—liver cancer	6.36e-05	0.000259	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KRAS—liver cancer	6.34e-05	0.000258	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDH1—liver cancer	6.29e-05	0.000256	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PRKCE—liver cancer	6.29e-05	0.000256	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CD—liver cancer	6.25e-05	0.000254	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PRKCE—liver cancer	6.24e-05	0.000254	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	6.21e-05	0.000252	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—GGT1—liver cancer	6.2e-05	0.000252	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—CYCS—liver cancer	6.01e-05	0.000244	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CD—liver cancer	6e-05	0.000244	CbGpPWpGaD
Auranofin—ALB—Hemostasis—ABL1—liver cancer	5.98e-05	0.000243	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IGF2—liver cancer	5.96e-05	0.000242	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ABL1—liver cancer	5.93e-05	0.000241	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CA—liver cancer	5.93e-05	0.000241	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CA—liver cancer	5.83e-05	0.000237	CbGpPWpGaD
Auranofin—ALB—Metabolism—GLUL—liver cancer	5.73e-05	0.000233	CbGpPWpGaD
Auranofin—ALB—Metabolism—CPT1B—liver cancer	5.73e-05	0.000233	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL2—liver cancer	5.7e-05	0.000232	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HGF—liver cancer	5.62e-05	0.000229	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—RAF1—liver cancer	5.58e-05	0.000227	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HGF—liver cancer	5.58e-05	0.000227	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CSF2—liver cancer	5.56e-05	0.000226	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADAM17—liver cancer	5.54e-05	0.000225	CbGpPWpGaD
Auranofin—ALB—Metabolism—NR1H4—liver cancer	5.52e-05	0.000225	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD8A—liver cancer	5.52e-05	0.000224	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CSF2—liver cancer	5.52e-05	0.000224	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HRAS—liver cancer	5.48e-05	0.000223	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CB—liver cancer	5.45e-05	0.000222	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MTOR—liver cancer	5.45e-05	0.000222	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTA3—liver cancer	5.43e-05	0.000221	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—HRAS—liver cancer	5.39e-05	0.000219	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—RAF1—liver cancer	5.36e-05	0.000218	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—liver cancer	5.25e-05	0.000213	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—MTOR—liver cancer	5.23e-05	0.000213	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CB—liver cancer	5.23e-05	0.000213	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	5.22e-05	0.000212	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PSMA4—liver cancer	5.2e-05	0.000212	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PSMD10—liver cancer	5.2e-05	0.000212	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—liver cancer	5.16e-05	0.00021	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1B—liver cancer	5.12e-05	0.000208	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTA4—liver cancer	4.97e-05	0.000202	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1B—liver cancer	4.91e-05	0.0002	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—JUN—liver cancer	4.87e-05	0.000198	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	4.85e-05	0.000197	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	4.85e-05	0.000197	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTA2—liver cancer	4.84e-05	0.000197	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CTNNB1—liver cancer	4.83e-05	0.000197	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKT1—liver cancer	4.76e-05	0.000194	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1A—liver cancer	4.72e-05	0.000192	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BCL2L1—liver cancer	4.72e-05	0.000192	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTA1—liver cancer	4.67e-05	0.00019	CbGpPWpGaD
Auranofin—ALB—Metabolism—NAT2—liver cancer	4.62e-05	0.000188	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK8—liver cancer	4.61e-05	0.000187	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1A—liver cancer	4.53e-05	0.000184	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MAPK14—liver cancer	4.5e-05	0.000183	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK14—liver cancer	4.47e-05	0.000182	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	4.45e-05	0.000181	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.44e-05	0.000181	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALDOB—liver cancer	4.43e-05	0.00018	CbGpPWpGaD
Auranofin—ALB—Hemostasis—F2—liver cancer	4.36e-05	0.000177	CbGpPWpGaD
Auranofin—ALB—Metabolism—CRABP1—liver cancer	4.22e-05	0.000172	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	4.22e-05	0.000172	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CG—liver cancer	4.18e-05	0.00017	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PRKCE—liver cancer	4.03e-05	0.000164	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF2—liver cancer	3.82e-05	0.000155	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDH1—liver cancer	3.81e-05	0.000155	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.8e-05	0.000155	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	3.78e-05	0.000154	CbGpPWpGaD
Auranofin—ALB—Metabolism—HPGDS—liver cancer	3.69e-05	0.00015	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CD—liver cancer	3.67e-05	0.000149	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.67e-05	0.000149	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CD—liver cancer	3.64e-05	0.000148	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SERPINE1—liver cancer	3.63e-05	0.000148	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KRAS—liver cancer	3.62e-05	0.000147	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CSF2—liver cancer	3.57e-05	0.000145	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—H2AFX—liver cancer	3.52e-05	0.000143	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KRAS—liver cancer	3.47e-05	0.000141	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.34e-05	0.000136	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CA—liver cancer	3.32e-05	0.000135	CbGpPWpGaD
Auranofin—ALB—Metabolism—PSMA4—liver cancer	3.29e-05	0.000134	CbGpPWpGaD
Auranofin—ALB—Metabolism—PSMD10—liver cancer	3.29e-05	0.000134	CbGpPWpGaD
Auranofin—ALB—Hemostasis—RAF1—liver cancer	3.28e-05	0.000133	CbGpPWpGaD
Auranofin—IKBKB—Immune System—RAF1—liver cancer	3.25e-05	0.000132	CbGpPWpGaD
Auranofin—ALB—Metabolism—GOT2—liver cancer	3.2e-05	0.00013	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CB—liver cancer	3.2e-05	0.00013	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CA—liver cancer	3.19e-05	0.00013	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TERT—liver cancer	3.18e-05	0.000129	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MTOR—liver cancer	3.17e-05	0.000129	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CB—liver cancer	3.17e-05	0.000129	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	3.09e-05	0.000126	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HRAS—liver cancer	3.07e-05	0.000125	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP2E1—liver cancer	3.01e-05	0.000122	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1B—liver cancer	2.98e-05	0.000121	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HRAS—liver cancer	2.95e-05	0.00012	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—liver cancer	2.94e-05	0.00012	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2—liver cancer	2.94e-05	0.00012	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2—liver cancer	2.92e-05	0.000119	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.91e-05	0.000118	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KDR—liver cancer	2.91e-05	0.000118	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK14—liver cancer	2.89e-05	0.000117	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	2.84e-05	0.000115	CbGpPWpGaD
Auranofin—IKBKB—Immune System—JUN—liver cancer	2.84e-05	0.000115	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ESR1—liver cancer	2.83e-05	0.000115	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYCS—liver cancer	2.82e-05	0.000114	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTNNB1—liver cancer	2.81e-05	0.000114	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—F2—liver cancer	2.8e-05	0.000114	CbGpPWpGaD
Auranofin—ALB—Metabolism—GOT1—liver cancer	2.76e-05	0.000112	CbGpPWpGaD
Auranofin—ALB—Metabolism—GGT1—liver cancer	2.76e-05	0.000112	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1A—liver cancer	2.75e-05	0.000112	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AKT1—liver cancer	2.71e-05	0.00011	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK8—liver cancer	2.68e-05	0.000109	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APC—liver cancer	2.68e-05	0.000109	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CG—liver cancer	2.68e-05	0.000109	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—AKT1—liver cancer	2.61e-05	0.000106	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—BRAF—liver cancer	2.52e-05	0.000102	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—liver cancer	2.5e-05	0.000102	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTP1—liver cancer	2.48e-05	0.000101	CbGpPWpGaD
Auranofin—IKBKB—Immune System—STAT3—liver cancer	2.45e-05	9.98e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—HMOX1—liver cancer	2.45e-05	9.95e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CD—liver cancer	2.35e-05	9.58e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SERPINE1—liver cancer	2.33e-05	9.47e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TGFB1—liver cancer	2.29e-05	9.32e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTM1—liver cancer	2.28e-05	9.27e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP1A1—liver cancer	2.16e-05	8.79e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KRAS—liver cancer	2.12e-05	8.64e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KRAS—liver cancer	2.11e-05	8.57e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RAF1—liver cancer	2.1e-05	8.55e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MTOR—liver cancer	2.05e-05	8.35e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CB—liver cancer	2.05e-05	8.35e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—MTHFR—liver cancer	2.02e-05	8.2e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARA—liver cancer	1.98e-05	8.04e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CA—liver cancer	1.95e-05	7.93e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CA—liver cancer	1.94e-05	7.87e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1B—liver cancer	1.93e-05	7.83e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASP3—liver cancer	1.89e-05	7.68e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—liver cancer	1.89e-05	7.67e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2—liver cancer	1.89e-05	7.67e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCND1—liver cancer	1.84e-05	7.47e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—JUN—liver cancer	1.83e-05	7.46e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CTNNB1—liver cancer	1.82e-05	7.4e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HRAS—liver cancer	1.8e-05	7.34e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HRAS—liver cancer	1.79e-05	7.28e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MMP9—liver cancer	1.78e-05	7.26e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1A—liver cancer	1.78e-05	7.23e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.78e-05	7.22e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK8—liver cancer	1.74e-05	7.06e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—liver cancer	1.71e-05	6.97e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CG—liver cancer	1.69e-05	6.89e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARG—liver cancer	1.63e-05	6.65e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—liver cancer	1.6e-05	6.52e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT1—liver cancer	1.59e-05	6.48e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STAT3—liver cancer	1.59e-05	6.45e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT1—liver cancer	1.58e-05	6.43e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CD—liver cancer	1.49e-05	6.05e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—liver cancer	1.47e-05	5.99e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TGFB1—liver cancer	1.47e-05	5.98e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KRAS—liver cancer	1.36e-05	5.54e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CB—liver cancer	1.3e-05	5.28e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CA—liver cancer	1.25e-05	5.09e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—liver cancer	1.21e-05	4.92e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HRAS—liver cancer	1.16e-05	4.71e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—liver cancer	1.11e-05	4.51e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT1—liver cancer	1.02e-05	4.16e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CA—liver cancer	7.91e-06	3.22e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKT1—liver cancer	6.46e-06	2.63e-05	CbGpPWpGaD
